RIZATRIPTAN 5 MG ODT
For 30 tablets
Pharmacies pay
$16.34 filed
30 × $0.54459 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$23.79 estimated
$16.34 + $2.45 (15%) + $5.00 fee per fill = $23.79
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
RIZATRIPTAN 5 MG ODT is how the CMS NADAC file names this product. The FDA NDC Directory lists it as rizatriptan benzoate.
FDA gives its dosage form as tablet, orally disintegrating and its route as oral.
FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Macleods Pharmaceuticals Limited, Rising Pharma Holdings, Inc. and Aurobindo Pharma Limited.
FDA’s Established Pharmacologic Class for it is Serotonin-1b and Serotonin-1d Receptor Agonist.
The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes); the FDA directory lists 7 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $16.34 for 30 tablets (30 × $0.54459 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 4 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Macleods Pharmaceuticals Limited | 3 | $0.54459 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.54459 per EA filed |
| Bionpharma Inc., | 1 | $0.54459 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $0.54459 per EA filed |
| Not listed as a package in the FDA directory | 3 | $0.54459 per EA filed |
All 10 NDCs, with labeler and price
- 33342-0093-02 · not listed as a package in the FDA directory · $0.54459 per EA · eff. 2026-09-23 filed
- 33342-0093-41 · Macleods Pharmaceuticals Limited · $0.54459 per EA · eff. 2026-09-23 filed
- 33342-0093-45 · Macleods Pharmaceuticals Limited · $0.54459 per EA · eff. 2026-09-23 filed
- 33342-0093-52 · Macleods Pharmaceuticals Limited · $0.54459 per EA · eff. 2026-09-23 filed
- 57237-0085-63 · Rising Pharma Holdings, Inc. · $0.54459 per EA · eff. 2026-09-23 filed
- 65862-0625-03 · not listed as a package in the FDA directory · $0.54459 per EA · eff. 2026-09-23 filed
- 65862-0625-12 · Aurobindo Pharma Limited · $0.54459 per EA · eff. 2026-09-23 filed
- 65862-0625-90 · Aurobindo Pharma Limited · $0.54459 per EA · eff. 2026-09-23 filed
- 69452-0156-73 · Bionpharma Inc., · $0.54459 per EA · eff. 2026-09-23 filed
- 69452-0156-74 · not listed as a package in the FDA directory · $0.54459 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share the FDA nonproprietary name rizatriptan benzoate with RIZATRIPTAN 5 MG ODT.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| MAXALT 10 MG TABLET | $44.4765 per EA filed | $40.70373 per EA filed |
| MAXALT MLT 10 MG TABLET | $44.21394 per EA filed | $41.07929 per EA filed |
| RIZATRIPTAN 5 MG ODT this page | $0.54459 per EA filed | We don’t know yet |
| RIZATRIPTAN 5 MG TABLET | $0.34799 per EA filed | $1.5334 per EA filed |
| RIZATRIPTAN 10 MG ODT | $0.50969 per EA filed | We don’t know yet |
| RIZATRIPTAN 10 MG TABLET | $0.33545 per EA filed | $1.5334 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 10 NDCs’ NADAC prices is $0.54459 per EA filed.
Of the 28 other products in FDA’s Serotonin-1b and Serotonin-1d Receptor Agonist class priced per EA, 22 have a higher middle NADAC price and 6 a lower one. The one in the middle is FROVATRIPTAN SUCC 2.5 MG TAB, at $2.71707 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- NARATRIPTAN HCL 1 MG TABLET
- ELETRIPTAN HBR 20 MG TABLET
- SUMATRIPTAN 20 MG NASAL SPRAY
- ZOLMITRIPTAN 2.5 MG ODT
- FROVATRIPTAN SUCC 2.5 MG TAB